Don't Miss

UM Ventures announces license deals

University of Maryland Ventures, a joint research commercialization effort of the University of Maryland, Baltimore, and the University of Maryland, College Park, announced license and/or option agreements with five life sciences companies across the Baltimore-Washington region. The companies are Rexahn Pharmaceuticals Inc., of Rockville; IGI Technologies Inc., of Elkridge; Plasmonix Inc., of Arbutus; A&G Pharmaceuticals Inc., ...

Print, Digital & Mobile

Special Monthly Autorenew Intro Rate!

3 Months

6 Months

1 Year

Digital & Mobile Only

1 Year

Leave a Reply

Your email address will not be published. Required fields are marked *


You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>

Scroll To Top